Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies for neurodegenerative diseases such as ALS, Wolfram syndrome, and progressive supranuclear palsy, as well as endocrine conditions like post-bariatric hypoglycemia.
Exelixis, Inc. is a biotechnology company focused on innovative cancer treatments, driven by a commitment to patient care and research excellence.
LTBased in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.
TPTris Pharma is a biopharmaceutical company dedicated to developing innovative therapies for ADHD, pain, addiction, and CNS disorders through proprietary technologies.
Acadia Pharmaceuticals is dedicated to pioneering innovative therapies for neurological disorders, focusing on elevating the lives of patients through dedicated research and community support.
Ultragenyx Pharmaceutical Inc. develops innovative medicines for rare and ultrarare diseases, focusing on transformative therapies across multiple indications.